Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
JP Stock MarketDetailed Quotes
1382 HOB
- 1797
- +1+0.06%
20min DelayMarket Closed Dec 30 15:30 JST
1.37BMarket Cap68.41P/E (Static)
1817High1771Low1.20KVolume1794Open1796Pre Close2.15MTurnover270152wk High0.42%Turnover Ratio762.00KShares155052wk Low26.27EPS TTM513.37MFloat Cap8770Historical High68.41P/E (Static)285.68KShs Float570Historical Low26.27EPS LYR2.56%Amplitude50.00Dividend TTM1.78P/B100Lot Size2.78%Div YieldTTM
HOB Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.19%2.52B | -3.21%361.07M | 3.76%741.53M | 8.79%1.04B | -15.66%373.92M | -4.43%2.49B | -11.31%373.06M | -15.31%714.69M | 3.90%958.28M | 6.10%443.34M |
| Cost of revenue | 7.79%1.97B | 5.26%271.09M | 6.73%586M | 17.07%849.48M | -11.02%260.46M | -4.96%1.82B | -7.49%257.55M | -18.09%549.02M | 3.29%725.64M | 8.82%292.73M |
| Gross profit | -16.92%551.99M | -22.11%89.98M | -6.12%155.54M | -17.03%193.02M | -24.67%113.46M | -2.94%664.43M | -18.79%115.51M | -4.60%165.67M | 5.85%232.64M | 1.18%150.61M |
| Operating expense | -1.90%519.28M | -1.32%119.63M | 0.08%128.57M | -2.77%136.02M | -3.34%135.07M | -1.34%529.32M | -2.82%121.23M | -1.61%128.46M | -1.57%139.9M | 0.47%139.74M |
| Staff costs | -5.36%147.32M | ---- | ---- | ---- | ---- | -2.36%155.66M | ---- | ---- | ---- | ---- |
| Selling and administrative expenses | -2.71%163.6M | ---- | ---- | ---- | ---- | -1.63%168.16M | ---- | ---- | ---- | ---- |
| -Selling and marketing expense | -2.71%163.6M | ---- | ---- | ---- | ---- | -1.63%168.16M | ---- | ---- | ---- | ---- |
| Other operating expenses | 1.39%208.36M | ---- | ---- | ---- | ---- | -0.31%205.5M | ---- | ---- | ---- | ---- |
| Operating profit | -75.79%32.71M | -418.57%-29.65M | -27.53%26.97M | -38.54%57M | -298.89%-21.62M | -8.72%135.11M | -132.69%-5.72M | -13.66%37.21M | 19.42%92.75M | 11.26%10.87M |
| Net non-operating interest income (expenses) | -18.92%-88K | 31.25%-11K | -115.00%-43K | -10.00%-22K | 33.33%-12K | 35.09%-74K | 27.27%-16K | 39.39%-20K | 31.03%-20K | 40.00%-18K |
| Non-operating interest income | 20.00%6K | --0 | 0.00%3K | --0 | 50.00%3K | 25.00%5K | --0 | 0.00%3K | --0 | 100.00%2K |
| Non-operating interest expense | 18.99%94K | -31.25%11K | 100.00%46K | 10.00%22K | -25.00%15K | -33.05%79K | -27.27%16K | -36.11%23K | -31.03%20K | -35.48%20K |
| Net investment income | -23.22%-260K | 52.12%-79K | 21.21%-26K | -187.14%-201K | -19.30%46K | -181.33%-211K | -114.29%-165K | -65.00%-33K | -94.44%-70K | -1.72%57K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 1,891.36%1.61M | 853.09%772K | 0 | 807K | 34K | -60.68%81K | -59.50%81K | 0 | 0 | 0 |
| Less:Other special charges | -1,891.36%-1.61M | ---772K | --0 | ---807K | ---34K | 60.68%-81K | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 25.23%4.96M | 186.51%3.31M | -78.23%209K | -23.90%1.23M | -8.15%214K | 134.28%3.96M | 109.04%1.16M | 208.68%960K | 106.52%1.62M | 406.52%233K |
| Income before tax | -71.96%38.94M | -450.25%-25.66M | -28.88%27.11M | -37.61%58.81M | -291.46%-21.33M | -7.34%138.87M | -125.70%-4.66M | -12.08%38.12M | 20.05%94.27M | 13.19%11.14M |
| Income tax | -33.65%18.92M | 47.26%-8.06M | -18.26%8.9M | -38.52%17.75M | -91.83%330K | 273.81%28.52M | 29.90%-15.28M | 11.32%10.89M | 67.51%28.86M | 67.76%4.04M |
| Net income | -81.87%20.01M | -265.83%-17.6M | -33.12%18.21M | -37.21%41.07M | -404.94%-21.66M | -22.42%110.35M | -73.42%10.61M | -18.90%27.23M | 6.71%65.41M | -4.48%7.1M |
| Net income continuous operations | -81.86%20.01M | -265.84%-17.6M | -33.13%18.21M | -37.21%41.07M | -404.93%-21.66M | -22.42%110.35M | -73.43%10.61M | -18.89%27.23M | 6.71%65.41M | -4.48%7.1M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -81.87%20.01M | -265.83%-17.6M | -33.12%18.21M | -37.21%41.07M | -404.94%-21.66M | -22.42%110.35M | -73.42%10.61M | -18.90%27.23M | 6.71%65.41M | -4.48%7.1M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -81.87%20.01M | -265.83%-17.6M | -33.12%18.21M | -37.21%41.07M | -404.94%-21.66M | -22.42%110.35M | -73.42%10.61M | -18.90%27.23M | 6.71%65.41M | -4.48%7.1M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -81.87%26.27 | -265.78%-23.11 | -33.15%23.9 | -37.20%53.92 | -404.82%-28.44 | -22.41%144.88 | -73.41%13.94 | -18.88%35.75 | 6.70%85.86 | -4.41%9.33 |
| Diluted earnings per share | -81.87%26.27 | -265.84%-23.11 | -33.13%23.9 | -37.20%53.9175 | -404.82%-28.44 | -22.41%144.88 | -73.42%13.9349 | -18.90%35.7418 | 6.70%85.86 | -4.41%9.33 |
| Dividend per share | 0.00%50 | 0.00%50 | 0 | 0 | 0 | 0.00%50 | 0.00%50 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |